Related references
Note: Only part of the references are listed.Stability liabilities of biotherapeutic proteins: Early assessment as mitigation strategy
Susana A. Lobo et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)
Developability assessment with case studies highlighting the decision taking
Jacques Dumas et al.
M S-MEDECINE SCIENCES (2020)
Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity
Yulei Zhang et al.
MOLECULAR PHARMACEUTICS (2020)
A single molecular descriptor to predict solution behavior of therapeutic antibodies
Jonathan S. Kingsbury et al.
SCIENCE ADVANCES (2020)
Rational optimization of a monoclonal antibody improves the aggregation propensity and enhances the CMC properties along the entire pharmaceutical process chain
Joschka Bauer et al.
MABS (2020)
Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies
Amita Datta-Mannan et al.
MABS (2020)
Five computational developability guidelines for therapeutic antibody profiling
Matthew I. J. Raybould et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Looking for therapeutic antibodies in next-generation sequencing repositories
Konrad Krawczyk et al.
MABS (2019)
Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfaces
Shira Warszawski et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Selecting and engineering monoclonal antibodies with drug-like specificity
Charles G. Starr et al.
CURRENT OPINION IN BIOTECHNOLOGY (2019)
Structure, heterogeneity and developability assessment of therapeutic antibodies
Yingda Xu et al.
MABS (2019)
Anti-PD1 SHR-1210' aberrantly targets pro-angiogenic receptors and this polyspecificity can be ablated by paratope refinement
William J. J. Finlay et al.
MABS (2019)
Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodies
Leonard D. Goldstein et al.
COMMUNICATIONS BIOLOGY (2019)
Integrating high-throughput screening and sequencing for monoclonal antibody discovery and engineering
Cristina Parola et al.
IMMUNOLOGY (2018)
Biopharmaceutical Informatics: supporting biologic drug development via molecular modelling and informatics
Sandeep Kumar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2018)
In Silico Prediction of Diffusion Interaction Parameter (k(D)), a Key Indicator of Antibody Solution Behaviors
Dheeraj S. Tomar et al.
PHARMACEUTICAL RESEARCH (2018)
In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions
Dheeraj S. Tomar et al.
MABS (2017)
Biophysical properties of the clinical-stage antibody landscape
Tushar Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development
Dheeraj S. Tomar et al.
MABS (2016)
FROM THE ANALYST'S COUCH Trends in clinical success rates
Katarzyna Smietana et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Solubis: a webserver to reduce protein aggregation through mutation
Joost Van Durme et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2016)
Developability Assessment During the Selection of Novel Therapeutic Antibodies
Alexander Jarasch et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics
Dhaval K. Shah
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2015)
The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies
Amita Datta-Mannan et al.
MABS (2015)
Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics
Amita Datta-Mannan et al.
MABS (2015)
Rational design of viscosity reducing mutants of a monoclonal antibody: Hydrophobic versus electrostatic inter-molecular interactions
Pilarin Nichols et al.
MABS (2015)
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Yvonne Rosenberg et al.
PLOS ONE (2015)
Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge
Bing Li et al.
MABS (2014)
Dipole-Dipole Interaction in Antibody Solutions: Correlation with Viscosity Behavior at High Concentration
Shubhadra N. Singh et al.
PHARMACEUTICAL RESEARCH (2014)
Concentration Dependent Viscosity of Monoclonal Antibody Solutions: Explaining Experimental Behavior in Terms of Molecular Properties
Li Li et al.
PHARMACEUTICAL RESEARCH (2014)
In silico selection of therapeutic antibodies for development: Viscosity, clearance, and chemical stability
Vikas K. Sharma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Christopher A. Lipinski et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Developability index: A rapid in silico tool for the screening of antibody aggregation propensity
Timothy M. Lauer et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Relationship between potential aggregation-prone regions and HLA-DR-binding T-cell immune epitopes: Implications for rational design of novel and follow-on therapeutic antibodies
Sandeep Kumar et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration
Yanan Zheng et al.
MABS (2012)
Mechanisms of self-association of a human monoclonal antibody CNTO607
Deidra Bethea et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Impact of Product-Related Factors on Immunogenicity of Biotherapeutics
Satish Kumar Singh
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Coupling of Aggregation and Immunogenicity in Biotherapeutics: T- and B-Cell Immune Epitopes May Contain Aggregation-Prone Regions
Sandeep Kumar et al.
PHARMACEUTICAL RESEARCH (2011)
Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics
C. Andrew Boswell et al.
BIOCONJUGATE CHEMISTRY (2010)
Potential Aggregation-Prone Regions in Complementarity-Determining Regions of Antibodies and Their Contribution Towards Antigen Recognition: A Computational Analysis
Xiaoling Wang et al.
PHARMACEUTICAL RESEARCH (2010)
Structure-based engineering of a monoclonal antibody for improved solubility
Sheng-Jiun Wu et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Epitope Mapping of Anti-Interleukin-13 Neutralizing Antibody CNTO607
Alexey Teplyakov et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Design of therapeutic proteins with enhanced stability
Naresh Chennamsetty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the AVASTIN™ Fab
G Fuh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Predicting the behaviour of proteins in hydrophobic interaction chromatography 1: Using the hydrophobic imbalance (HI) to describe their surface amino acid distribution
JC Salgado et al.
JOURNAL OF CHROMATOGRAPHY A (2006)
Drug-like properties and the causes of poor solubility and poor permeability
CA Lipinski
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)
Share Paper
